Publications


Correction to: Built Environment and Cardiovascular Diseases – Insights from a Global Review (Current Atherosclerosis Reports, (2025), 27, 1, (36), 10.1007/s11883-025-01282-2);
Noorali, AA, Merchant, AAH, Afzal, N, Sen, R, Junaid, V, Khoja, A, Al-Kindi, S, Vaughan, EM, Khan, UI, Safdar, NF, Virani, SS & Sheikh, S 2025, , Current Atherosclerosis Reports, vol. 27, no. 1, 43. https://doi.org/10.1007/s11883-025-01293-z

The built environment and adverse cardiovascular events in US veterans with cardiovascular disease;
Moorthy, S, Chen, Z, Zhang, T, Ponnana, SR, Sirasapalli, SK, Shivanantham, K, Khraishah, H, Dazard, JE, Al-Kindi, SG, Deo, SV & Rajagopalan, S 2025, , Science of the Total Environment, The, vol. 980, 179596. https://doi.org/10.1016/j.scitotenv.2025.179596

Chronic kidney disease prevalence and outcomes in patients with type 2 diabetes or prediabetes at high cardiovascular risk: results from the CINEMA program;
Datla, S, Albar, Z, Eaton, E, Porges, J, Nennstiel, M, Sullivan, C, Greene, L, Al-Kindi, SG, Montgomery, E, Padiyar, A, Kosiborod, M, Magwire, ML, Rahman, M, Rajagopalan, S & Neeland, IJ 2025, , American Journal of Preventive Cardiology, vol. 22, 101004. https://doi.org/10.1016/j.ajpc.2025.101004

Hidden risk revealed: The prognostic power of coronary calcium in HIV;
Alwan, M, Al-Mallah, MH & Al Rifai, M 2025, , Atherosclerosis, vol. 405, 119228. https://doi.org/10.1016/j.atherosclerosis.2025.119228

Disparities in statin use in patients with ASCVD with vs without rheumatologic diseases in a large integrated healthcare system: Houston methodist CVD learning health system registry;
Avenatti, E, DiGregorio, H, Hajj, EE, Gullapelli, R, Williams, K, Shahid, I, Bose, B, Hagan, K, Nicolas, JC, Lahan, S, Nwana, N, Butt, SA, Monga, K, Karam, LAR, Guevara, M, Javed, Z, Weber, B, Al-Kindi, S & Nasir, K 2025, , American Journal of Preventive Cardiology, vol. 22, 100959. https://doi.org/10.1016/j.ajpc.2025.100959

Composite socio-environmental risk score for cardiovascular assessment: An explainable machine learning approach;
Chen, Z, Dazard, JE, Salerno, PRVDO, Sirasapalli, SK, Makhlouf, MHE, Rajagopalan, S & Al-Kindi, S 2025, , American Journal of Preventive Cardiology, vol. 22, 100964. https://doi.org/10.1016/j.ajpc.2025.100964

State-Level Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in the United States, 2011 to 2023;
Chang, R, Parekh, T, Hagan, KK, Javed, Z & Ostrominski, JW 2025, , JACC: Advances, vol. 4, no. 6P1, 101754. https://doi.org/10.1016/j.jacadv.2025.101754

In Vivo Assessment of Cardiac Radiofrequency Ablation in a Large-Animal Model Using Photoacoustic-Ultrasound Imaging;
Mathuria, N, Vishwanath, K, Fallon, BC, Martino, A, Brero, G, Willson, RC, Valderrabano, M, Filgueira, CS & Bouchard, RR 2025, , JACC: Clinical Electrophysiology, vol. 11, no. 5, pp. 1024-1029. https://doi.org/10.1016/j.jacep.2025.02.031

An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists;
Dani, SS, Makwana, B, Khadke, S, Kumar, A, Jhund, P, Nasir, K, Sattar, N, Al-Kindi, S, Fonarow, G, Butler, J, Bhatt, DL, Kosiborod, MN, Nohria, A & Ganatra, S 2025, , JACC: Advances, vol. 4, no. 5, 101740. https://doi.org/10.1016/j.jacadv.2025.101740

Probing the shadows of myocardial scar: Can PET MPI see what MRI sees?;
Osborne, MT & Al-Mallah, MH 2025, , Journal of Nuclear Cardiology, vol. 47, 102221. https://doi.org/10.1016/j.nuclcard.2025.102221